about
Clinical Importance of Somatostatin Receptor 2 (SSTR2) and Somatostatin Receptor 5 (SSTR5) Expression in Thyrotropin-Producing Pituitary Adenoma (TSHoma).Clinical review: Pituitary carcinoma: difficult diagnosis and treatmentPhospho-histone H3 (pHH3) immuno-reactivity as a prognostic marker in non-functioning pituitary adenomas.Multimodality treatment for invasive pituitary adenomas.Key signaling molecules in pituitary tumors.Isolation and characterization of novel pituitary tumor related genes: a cDNA representational difference approach.Pituitary carcinoma diagnosed on fine needle aspiration: Report of a case and review of pathogenesis.Clinical implications of growth hormone-secreting tumor subtypes.Pituitary centers of excellence.Management of aggressive pituitary adenomas and pituitary carcinomas.Emerging Targets in Pituitary Adenomas: Role of the CXCL12/CXCR4-R7 System.Metalloproteinases ADAM12 and MMP-14 are associated with cavernous sinus invasion in pituitary adenomas.Radiotherapy with concurrent temozolomide for the management of extraneural metastases in pituitary carcinoma.Predictive value of PWI for blood supply and T1-spin echo MRI for consistency of pituitary adenoma.Expression and Clinical Significance of miR-26a and Pleomorphic Adenoma Gene 1 (PLAG1) in Invasive Pituitary Adenoma.Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement.Perioperative cortisol can predict hypothalamus-pituitary-adrenal status in clinically non-functioning pituitary adenomas.Clinicopathological investigation of vascular endothelial growth factor and von Hippel-Lindau gene-related protein expression in immunohistochemically negative pituitary adenoma--possible involvement in tumor aggressiveness.MGMT immunoexpression in growth hormone-secreting pituitary adenomas and its correlation with Ki-67 labeling index and cytokeratin distribution pattern.Silent somatotroph pituitary adenomas: an update.Mid-term prognosis of non-functioning pituitary adenomas with high proliferative potential: really an aggressive variant?Clinical profile of silent growth hormone pituitary adenomas; higher recurrence rate compared to silent gonadotroph pituitary tumors, a large single center experience.Clinicopathological study of prognostic factors in patients with pituitary adenomas and Ki-67 labeling index of more than 3%.MicroRNA involvement in a metastatic non-functioning pituitary carcinoma.
P2860
Q33620709-41A0F55A-3F41-482D-9C04-04D9232CBBFDQ35750569-37F3C2F7-2594-483A-90E8-AEF7942AE0E0Q37367647-0C97091D-B04C-4C82-9DBA-35A979D1207DQ37427263-145B8016-5B54-41FB-88EA-213623740EFEQ37628691-91CB8F32-4FEA-4105-AAA7-4751F2BD8374Q37704785-8E0FD665-8965-401F-A16A-79D7DBA9EEFAQ37784148-08A1CD22-9F0F-475D-A69C-B6E953C65006Q37995533-F579753E-657B-4AF1-B303-C5E084B29450Q38035640-5901D388-40C0-4CA4-B2DC-1D003759EADBQ38192486-DCB39793-AB53-4510-AAC3-B4B2C11B0CB4Q38284921-3629DD42-DB09-4D97-BB2E-49AC28D71631Q38773281-363CA567-FF6C-4BD3-9928-53E16152D769Q39829276-87634A92-90C5-4455-9441-D4559F0718E2Q40533045-3F7B643F-9973-4550-B352-05927A8D08D2Q40556608-DFE84C9A-3FB3-4000-8F86-BCF452323F10Q42361469-82AB1CBC-D486-43C2-AA34-5DD3F38860D9Q42454820-F3F31551-FECE-45EB-AC56-BD4A00EE9E3CQ44312255-AB279159-4B53-491B-A580-A86A2DC0266AQ45761917-B3ED2E8B-1323-4A7D-A5D4-A89AE56EA54AQ47203293-DC00D128-709A-4973-BD6A-84EBAD3698AFQ47566183-4517595C-1574-4942-8FD8-69380A369B5BQ47606375-9CFCDA0D-7859-48AB-BB2B-BB760FED25C0Q51826070-7C5D7C77-7CF0-433D-8101-70B8B84CE0ECQ53547121-3D021B5D-1D22-4D80-A375-F8C2620E3AD9
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Classification and pathology of pituitary tumors.
@ast
Classification and pathology of pituitary tumors.
@en
type
label
Classification and pathology of pituitary tumors.
@ast
Classification and pathology of pituitary tumors.
@en
prefLabel
Classification and pathology of pituitary tumors.
@ast
Classification and pathology of pituitary tumors.
@en
P356
P1433
P1476
Classification and pathology of pituitary tumors.
@en
P2093
George Kontogeorgos
P2888
P356
10.1385/ENDO:28:1:027
P577
2005-10-01T00:00:00Z
P6179
1028101524